Out of stock

Buy Accrufer (ferric maltol) Online

0 out of 5

  • DISEASE INDICATIONS: Iron deficiency
  • MANUFACTURER: Shield Therapeutics
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Swissmedic (CH)
Accrufer, whose generic name is ferric maltol, is a prescription medication used in the treatment of iron-deficiency anemia in adults with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis, who have had an inadequate response to oral iron supplements.

Read more
Add to wishlist

Buy Adakveo (crizanlizumab) Online

5.00 out of 5

  • DISEASE INDICATIONS: Sickle Cell Disease
  • MANUFACTURER: Novartis
  • USAGE: Intravenous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
Adakveo, with the generic name crizanlizumab, is a prescription medication used for the prevention of vaso-occlusive crises (VOCs) in individuals with sickle cell disease (SCD).

$1,894.20
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

5.00 out of 5

  • DISEASE INDICATIONS: Thromboembolism
  • MANUFACTURER: Alexion Pharmaceuticals
  • USAGE: Intravenous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
Andexxa, with the generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used for the reversal of anticoagulation effects caused by certain direct oral anticoagulants (DOACs) that target factor Xa. This medication is designed to rapidly reverse the anticoagulant effects of DOACs, which are commonly used to prevent or treat blood clots but can pose a risk of excessive bleeding in certain situations.

$24,706.00
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Cablivi (caplacizumab) Online

5.00 out of 5

  • DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP)
  • MANUFACTURER: Ablynx NV
  • USAGE: Intravenous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Health Canada
  • Therapeutic Goods Administration (TGA)
Cablivi, with the generic name caplacizumab, is a prescription medication used in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening blood disorder.

$4,236.10
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Evrenzo (Roxadustat) Online

5.00 out of 5

  • DISEASE INDICATIONS: Anemia
  • MANUFACTURER: Astellas Pharma Inc. FibroGen
  • USAGE: Intravenous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
Evrenzo (roxadustat) is an oral medication used to treat anemia in adults with chronic kidney disease (CKD).

From $176.00
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Feraccru (ferric maltol) Online

0 out of 5

  • DISEASE INDICATIONS: Iron deficiency
  • MANUFACTURER: Shield Therapeutics
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Swissmedic (CH)
Feraccru, with the generic name ferric maltol, is a prescription medication used in the treatment of iron-deficiency anemia in adults with inflammatory bowel disease (IBD).

$167.20
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist
Out of stock

Buy Givlaari (givosiran) Online

0 out of 5

  • DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP)
  • MANUFACTURER: Alnylam Pharmaceuticals
  • USAGE: Subcutaneous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
Givlaari, with the generic name givosiran, is a prescription medication used for the treatment of acute hepatic porphyria (AHP) in adults.

Read more
Add to wishlist

Buy Inrebic (fedratinib) Online

0 out of 5

  • DISEASE INDICATIONS: Myelofibrosis
  • MANUFACTURER: Impact Biomedicines, Inc.
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
Inrebic, with the generic name fedratinib, is a prescription medication used in the treatment of certain types of myelofibrosis, a rare bone marrow disorder.

$5,382.30
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Ondexxya (andexanet alfa) Online

0 out of 5

DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ondexxya, with the generic name andexanet alfa, is a prescription medication used for the reversal of anticoagulation effects caused by certain direct and indirect oral anticoagulants (blood thinners). This medication is designed to rapidly reverse the anticoagulant effects of these drugs, which can be necessary in emergency situations such as uncontrolled bleeding or the need for urgent surgery.

$16,859.70
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Oxbryta (voxelotor) Online

0 out of 5

  • DISEASE INDICATIONS: Sickle Cell Disease
  • MANUFACTURER: Global Blood Therapeutics, Inc.
  • USAGE: Oral
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
Oxbryta, with the generic name voxelotor, is a prescription medication used in the treatment of sickle cell disease (SCD), a genetic blood disorder characterized by the presence of abnormally shaped red blood cells (sickle cells).

$33,957.00
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist

Buy Ultomiris (ravulizumab) Online

0 out of 5

  • MANUFACTURER: Alexion Pharmaceuticals
  • USAGE: Intravenous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
Ultomiris, with the generic name ravulizumab, is a prescription medication used in the treatment of two rare and serious blood disorders: paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Read more
Add to wishlist